The Koch Institute Symposium, held each spring at MIT, focuses on cutting edge research that holds new promise for understanding and conquering human disease. more >>
KI researchers describe potent immuno-suppressive activity of prostate cancer microenvironment more >>
KI's integrative research approach highlighted as a leading example more >>
KI's Swanson Biotechnology Center plays important role in uncovering why people react differently to chemotherapy more >>
New MEMS chip for cell sizing seen as revolutionary science. more >>
Alnylam and KI collaborators publish new research on RNAi mediated gene silencing of PCSK9, a genetically validated regulator of LDL metabolism. more >>
MIT engineers and biologists seek to optimize potential treatments. more >>
Published in Science, KI researcher define novel changes in 3'UTR and microRNAs in cancer cells. more >>
Tyler Jacks, director of the Koch Institute, discusses his vision for the new center and the cancer research that will take place there in this interview with MIT News Office writer Anne Trafton. more >>
MIT has announced a $100 million gift from Koch Industries executive and MIT alumnus David H. Koch that will usher in new paradigms in highly integrative cancer research. The gift will bring together MIT scientists and engineers under one roof to develop new and powerful ways to detect, diagnose, treat, and manage this often deadly disease. more >>
MIT Institute Professor Robert Langer has won the Millennium Technology Prize, the world's largest award for technology innovation. more >>
A team of researchers from MIT and Alnylam Pharmaceuticals has developed safe and effective methods to perform RNA interference, a therapy that holds great promise for treating a variety of diseases including cancer and hepatitis. more >>
MIT broke ground on Friday for the new David H. Koch Institute for Integrative Cancer Research, a facility that its director, Tyler Jacks, said will usher in "the next generation in cancer research." more >>
Snippets of genetic material that have been linked to cancer also play a critical role in normal embryonic development in mice, according to a new paper from MIT cancer biologists. more >>
A UCLA cancer study reported in this month's Nature Nanotechnology validates earlier work by MIT engineers, and is emblematic of an explosion in research at the intersections of engineering, the life sciences and medicine, according to MIT Dean of Engineering Subra Suresh. more >>
MIT researchers have devised a novel way to create tiny colonies of living human liver cells that model the full-sized organ. The work could allow better screening of new drugs that are potentially harmful to the liver and reduce the costs associated with their development. more >>
MIT scientists have devised remotely controlled nanoparticles that, when pulsed with an electromagnetic field, release drugs to attack tumors. The innovation, reported in the Nov. 15 online issue of Advanced Materials, could lead to the improved diagnosis and targeted treatment of cancer. more >>
MIT and University of Rochester researchers report important advances toward a therapeutic device that has the potential to capture cells as they flow through the blood stream and treat them. Among other applications, such a device could zap cancer cells spreading to other tissues, or signal stem cells to differentiate. more >>
MIT Professor Angelika Amon and Todd R. Golub of the Broad Institute of MIT and Harvard will share the 2007 Paul Marks Prize for Cancer Research, an award of $150,000, with Gregory J. Hannon from Cold Spring Harbor Laboratory. more >>
